Insights

Non-opioid focus Neumentum is dedicated to non-opioid analgesics with lead candidates NTM-001 (IV ketorolac) and NTM-006 (oral analgesic licensed from Janssen), positioning as a preferred partner for pain management solutions amid opioid-reduction trends.

Phase 3 Momentum NTM-001 is in Phase 3 for continuous IV infusion in postoperative pain, offering potential for a first-in-class NSAID continuous infusion, which could drive early access deals, co-development, or exclusive regional licensing.

Strategic licensing NTM-006 was licensed from Janssen/McNeil, indicating a track record of collaboration with large pharma, suggesting appetite for strategic partnerships, option rights, or milestone-driven collaborations to expand market reach.

Global expansion potential Partnerships like Nuance Pharma for Greater China on NTM-001 show a pathway for regional licensing and distribution deals to accelerate global adoption in diverse markets.

Smaller team, targeted sales With a lean team and early-stage funding, opportunities exist to position Neumentum with contract manufacturing, CRO/CMO partnerships, and co-promotion arrangements to scale commercialization without heavy internal headcount.

Similar companies to Neumentum, Inc.

Neumentum, Inc. Tech Stack

Neumentum, Inc. uses 8 technology products and services including iCIMS, WordPress, Shopify, and more. Explore Neumentum, Inc.'s tech stack below.

Media & News

Neumentum, Inc.'s Email Address Formats

Neumentum, Inc. uses at least 1 email format:
Neumentum, Inc. Email FormatsExamplePercentage
FirstLast@neumentum.comJohnDoe@neumentum.com
100%

Frequently Asked Questions

What is Neumentum, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Neumentum, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Neumentum, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Neumentum, Inc.'s official website is neumentum.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Neumentum, Inc. generate?

Minus sign iconPlus sign icon
As of August 2026, Neumentum, Inc.'s annual revenue is estimated to be $1M - $10M.

What is Neumentum, Inc.'s NAICS code?

Minus sign iconPlus sign icon
Neumentum, Inc.'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Neumentum, Inc. have currently?

Minus sign iconPlus sign icon
As of August 2026, Neumentum, Inc. has approximately 3 employees across 3 continents, including North America, Europe and South America. Key team members include : E. B. Explore Neumentum, Inc.'s employee directory with LeadIQ.

What industry does Neumentum, Inc. belong to?

Minus sign iconPlus sign icon
Neumentum, Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does Neumentum, Inc. use?

Minus sign iconPlus sign icon
Neumentum, Inc.'s tech stack includes iCIMS, WordPress, Shopify, Google Workspace, Really Simple Discovery, Google Analytics, Piwik PRO Core and LiteSpeed.

What is Neumentum, Inc.'s email format?

Minus sign iconPlus sign icon
Neumentum, Inc.'s email format typically follows the pattern of FirstLast@neumentum.com. Find more Neumentum, Inc. email formats with LeadIQ.

How much funding has Neumentum, Inc. raised to date?

Minus sign iconPlus sign icon
As of August 2026, Neumentum, Inc. has raised $35M in funding. The last funding round occurred on Nov 20, 2021 for $17M.
Neumentum, Inc. logo

Neumentum, Inc.

Pharmaceutical ManufacturingNew Jersey, United States2-10 Employees

Neumentum, Inc. is a pharmaceutical manufacturing company focused on developing non-opioid analgesics and neurology specialty therapies. Its portfolio includes four novel non-opioid products aimed at treating pain, with lead candidates NTM-001, an intravenous formulation of ketorolac expected to provide continuous analgesia over 24 hours, and NTM-006, an oral analgesic licensed from Janssen and McNeil. The company targets pain management needs in the United States and globally, seeking options with reduced risks of abuse, misuse, diversion, and opioid-related side effects. Neumentum operates in Morristown, New Jersey, and is led by an executive team experienced in pain and neurology from development to commercialization. The organization positions itself within the pharmaceutical industry as a developer of non-opioid pain therapies, emphasizing advancement beyond current pain treatments. A recent development noted is the ongoing progression of its lead candidates through clinical studies, including NTM-001 in Phase 3 and NTM-006 in Phase 2.

Section iconCompany Overview

Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
2-10

Section iconFunding & Financials

  • $35M

    Neumentum, Inc. has raised a total of $35M of funding over 5 rounds. Their latest funding round was raised on Nov 20, 2021 in the amount of $17M as a Venture Round.

  • $1M - $10M

    Neumentum, Inc.'s revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.